Loading insider details...
Latest Form 4 (Jun 5, 2026): Grant/Award of 35,500 ABOS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 35,500 | n/a |
| Jun 5, 2025 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 12,800 | n/a |
| Jun 10, 2024 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 25,000 | n/a |
| Jun 6, 2024 | Cara Therapeutics, Inc. (CARA) | Grant/Award | 150,647 | n/a |
| Aug 18, 2023 | Acumen Pharmaceuticals, Inc. (ABOS) | Exercise/Conversion | 39,149 | $28.2K |
| Jun 7, 2023 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 25,000 | n/a |
| Jun 5, 2023 | Cara Therapeutics, Inc. (CARA) | Grant/Award | 32,362 | n/a |
| Jul 19, 2022 | Cara Therapeutics, Inc. (CARA) | Sale | 3,600 | $32.6K |
| Jun 17, 2022 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 25,000 | n/a |
| Jun 6, 2022 | Cara Therapeutics, Inc. (CARA) | Grant/Award | 11,876 | n/a |